Thrivent Financial for Lutherans Trims Stock Holdings in Exponent, Inc. (NASDAQ:EXPO)

Thrivent Financial for Lutherans reduced its stake in Exponent, Inc. (NASDAQ:EXPO) by 3.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,340 shares of the business services provider’s stock after selling 443 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Exponent were worth $1,174,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in EXPO. Campbell & CO Investment Adviser LLC lifted its position in shares of Exponent by 9.1% in the fourth quarter. Campbell & CO Investment Adviser LLC now owns 5,349 shares of the business services provider’s stock valued at $471,000 after acquiring an additional 446 shares in the last quarter. CIBC Private Wealth Group LLC lifted its position in Exponent by 69.4% during the fourth quarter. CIBC Private Wealth Group LLC now owns 9,158 shares of the business services provider’s stock worth $806,000 after buying an additional 3,753 shares during the period. Congress Asset Management Co. MA lifted its position in Exponent by 30.3% during the fourth quarter. Congress Asset Management Co. MA now owns 52,157 shares of the business services provider’s stock worth $4,592,000 after buying an additional 12,138 shares during the period. Vanguard Group Inc. lifted its position in Exponent by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 4,995,605 shares of the business services provider’s stock worth $439,813,000 after buying an additional 19,795 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund lifted its position in Exponent by 30.7% during the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 48,998 shares of the business services provider’s stock worth $4,314,000 after buying an additional 11,498 shares during the period. 92.37% of the stock is currently owned by hedge funds and other institutional investors.

Exponent Trading Up 0.9 %

NASDAQ EXPO opened at $114.63 on Friday. The business’s 50-day moving average price is $107.06 and its 200 day moving average price is $96.92. Exponent, Inc. has a twelve month low of $64.61 and a twelve month high of $115.61. The company has a market capitalization of $5.81 billion, a PE ratio of 57.89 and a beta of 0.66.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.57 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.07. The company had revenue of $132.43 million for the quarter, compared to the consensus estimate of $130.83 million. Exponent had a return on equity of 28.39% and a net margin of 19.35%. The company’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same period last year, the business posted $0.50 EPS. Equities analysts predict that Exponent, Inc. will post 2.04 EPS for the current year.

Exponent Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 20th. Stockholders of record on Friday, September 6th were issued a $0.28 dividend. The ex-dividend date was Friday, September 6th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.98%. Exponent’s dividend payout ratio (DPR) is 56.57%.

Insider Transactions at Exponent

In other news, VP John Pye sold 3,956 shares of the firm’s stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total value of $415,380.00. Following the transaction, the vice president now directly owns 28,422 shares in the company, valued at $2,984,310. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 2.10% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Truist Financial reiterated a “buy” rating and set a $120.00 target price (up from $100.00) on shares of Exponent in a research report on Friday, July 26th.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.